• Ventus Therapeutics tacks on $100M to take on ‘undruggable' disease targets

    12 days ago - By MedCity News

    RA Capital led Ventus Therapeutics' Series B financing, which the startup will use to develop its pipeline of medicines for “undruggable” disease targets. CEO Marcelo Bigal said the cash also gives Ventus the flexibility to consider an IPO.
    Read more ...